Jonathan Zalevsky - Chief R&D Officer at NEKTAR THERAPEUTICS

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief R&D Officer
Issuer Symbol
NKTR on Nasdaq
All Insider Reports
All Insider Reports

Jonathan Zalevsky - trading volume in the past year for NEKTAR THERAPEUTICS

Holdings reported by Jonathan Zalevsky for NEKTAR THERAPEUTICS

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 21,354 $761,697 $35.67 20 Jan 2026 Direct
Stock Option 25,000 22 Dec 2025 Direct Common Stock

Transactions reported by Jonathan Zalevsky for NEKTAR THERAPEUTICS

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.